GFAP and metabolic disease: Longitudinal tracking of glial fibrillary acidic protein (GFAP)/ neurofilament light chain (NfL) in diverse populations. Mechanistic studies on neuroinflammation in metabolic disorders. Exploration of combo biomarkers (e.g., GFAP+vascular markers).